Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 14989327

Assessing competence in finding and reporting abnormal morphologic features while scanning peripheral blood smears.

A P Leach·D E Haun
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To develop a competency assessment tool to determine if technologists are detecting and reporting clinically significant findings on blood smears and to identify if proficiency improves through education using a video presentation. DESIGN: Combination of nonequivalent pretest-post test control group and modified time-series design. SETTING: A large medical center in Southern Louisiana. PARTICIPANTS: All shifts of technologists working in the Core Hematology and Special Hematology Laboratories. This sample is a nonprobability sample of convenience. INTERVENTION: A thirty-five minute videotape on the standardization of RBC morphology. MAIN OUTCOMES MEASURE: Develop a method for measuring competency of technologists who perform scans of peripheral blood smears as part of the automated white blood count differential process.

Explore related subjects

Blood CellsErythrocyte IndicesErythrocytesHematologic TestsLeukocyte CountProfessional CompetenceJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A P Leach, D E Haun. 2000. Assessing competence in finding and reporting abnormal morphologic features while scanning peripheral blood smears.. https://pubmed.ncbi.nlm.nih.gov/14989327/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.

BACKGROUND: Psoriasis is a chronic inflammatory skin disease that can be successfully treated with a mixture of fumaric acid esters (FAE) formulated as enteric-coated tablets for oral use. These tablets consist of dimethylfumarate (DMF) and salts of monoethylfumarate (MEF) and its main bioactive metabolite is monomethylfumarate (MMF). Little is known about the pharmacokinetics of these FAE. The aim of the present study was to investigate the hydrolysis of DMF to MMF and the stability of MMF, DMF and MEF at in vitro conditions representing different body compartments. RESULTS: DMF is hydrolyzed to MMF in an alkaline environment (pH 8), but not in an acidic environment (pH 1). In these conditions MMF and MEF remained intact during the period of analysis (6 h). Interestingly, DMF was hardly hydrolyzed to MMF in a buffer of pH 7.4, but was rapidly hydrolyzed in human serum having the same pH. Moreover, in whole blood the half-life of DMF was dramatically reduced as compared to serum. The concentrations of MMF and MEF in serum and whole blood decreased with increasing time. These data indicate that the majority of the FAE in the circulation are metabolized by one or more types of blood cells. Additional experiments with purified blood cell fractions resuspended in phosphate buffered saline (pH 7.4) revealed that at concentrations present in whole blood monocytes/lymphocytes, but not granulocytes and erythrocytes, effectively hydrolyzed DMF to MMF. Furthermore, in agreement with the data obtained with the pure components of the tablet, the enteric-coated tablet remained intact at pH 1, but rapidly dissolved at pH 8. CONCLUSION: Together, these in vitro data indicate that hydrolysis of DMF to MMF rapidly occurs at pH 8, resembling that within the small intestines, but not at pH 1 resembling the pH in the stomach. At both pHs MMF and MEF remained intact. These data explain the observation that after oral FAE intake MMF and MEF, but not DMF, can be readily detected in the circulation of human healthy volunteers and psoriasis patients.

Blood Cells↗
PubMed2004

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.

Emerging evidence to support the use of endothelial progenitor cells (EPCs) for angiogenic therapies or as biomarkers to assess cardiovascular disease risk and progression is compelling. However, there is no uniform definition of an EPC, which makes interpretation of these studies difficult. Although hallmarks of stem and progenitor cells are their ability to proliferate and to give rise to functional progeny, EPCs are primarily defined by the expression of cell-surface antigens. Here, using adult peripheral and umbilical cord blood, we describe an approach that identifies a novel hierarchy of EPCs based on their clonogenic and proliferative potential, analogous to the hematopoietic cell system. In fact, some EPCs form replatable colonies when deposited at the single-cell level. Using this approach, we also identify a previously unrecognized population of EPCs in cord blood that can achieve at least 100 population doublings, replate into at least secondary and tertiary colonies, and retain high levels of telomerase activity. Thus, these studies describe a clonogenic method to define a hierarchy of EPCs based on their proliferative potential, and they identify a unique population of high proliferative potential-endothelial colony-forming cells (HPP-ECFCs) in human umbilical cord blood.

Blood Cells↗